Changes

Jump to navigation Jump to search
no edit summary
Line 77: Line 77:  
''There are three types of pages:''
 
''There are three types of pages:''
   −
''(1)   Disease category overview pages (for example see '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', which are summaries of a group of diseases with links to all relevant content.''
+
''(1)   Disease category overview pages (for example see '''<u>[[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', which are summaries of a group of diseases with links to all relevant content.''
    
''(2)   Disease-specific pages (for example see any of the links on the AML overview page), which is for individual disease entities and much more detailed.''
 
''(2)   Disease-specific pages (for example see any of the links on the AML overview page), which is for individual disease entities and much more detailed.''
Line 126: Line 126:  
''Please discuss with the Associate Editor for your area as they will work with you to find a timeline that makes sense for you.''  
 
''Please discuss with the Associate Editor for your area as they will work with you to find a timeline that makes sense for you.''  
   −
17.  
+
17.   Can I modify a page that has already been completed by other authors?
   −
Of note, the CCGA is a wiki-based platform with the intention that contributors can modify any page at any time if something is not accurate or new evidence and references would be beneficial to share. This will allow up-to-date accurate content to be available to the community. Primary authorship will typically be listed as those individuals that initially completed the page content, and inquiries can be made by [Mailto:CCGA@cancergenomics.org <u>Email</u>] if a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section.
+
''Yes! The CCGA is a wiki-based platform with the intention that contributors can modify any page at any time if something is not accurate or new evidence and references would be beneficial to share. This will allow up-to-date accurate content to be available to the community. Primary authorship will typically be listed as those individuals that initially completed the page content, and inquiries can be made by [Mailto:CCGA@cancergenomics.org <u>Email</u>] if a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section.''
       
'''<u>Technical Issues</u>'''
 
'''<u>Technical Issues</u>'''
   −
17.  What should I do if I am experience technical issues when uploading content or using the site?
+
18.  What should I do if I am experience technical issues when uploading content or using the site?
    
''Please contact your Associate Editor who can either resolve your issue or follow up with '''[Mailto:CCGA@cancergenomics.org <u>CCGA@cancergenomics.org </u>]''' for technical assistance. If you have a major technical issue or something time sensitive, please include '''[Mailto:CCGA@cancergenomics.org <u>CCGA@cancergenomics.org </u>]''' on your initial email to your Associate Editor.''
 
''Please contact your Associate Editor who can either resolve your issue or follow up with '''[Mailto:CCGA@cancergenomics.org <u>CCGA@cancergenomics.org </u>]''' for technical assistance. If you have a major technical issue or something time sensitive, please include '''[Mailto:CCGA@cancergenomics.org <u>CCGA@cancergenomics.org </u>]''' on your initial email to your Associate Editor.''

Navigation menu